2019 Q4 Form 10-Q Financial Statement

#000169853019000146 Filed on November 07, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q4
Revenue $310.0K $527.0K $6.000K
YoY Change 5066.67% 824.56% -99.71%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.150M $2.230M $1.870M
YoY Change 14.97% 16.15% -16.52%
% of Gross Profit
Research & Development $8.270M $4.245M $3.010M
YoY Change 174.75% 6.1% 6.36%
% of Gross Profit
Depreciation & Amortization $120.0K $100.0K $90.00K
YoY Change 33.33% 11.11% 28.57%
% of Gross Profit
Operating Expenses $10.42M $6.473M $4.870M
YoY Change 113.96% 9.34% -3.94%
Operating Profit -$5.946M
YoY Change 1.42%
Interest Expense $520.0K $203.0K -$180.0K
YoY Change -388.89% 19.41% 0.0%
% of Operating Profit
Other Income/Expense, Net -$400.0K $130.0K $290.0K
YoY Change -237.93% -75.88% 480.0%
Pretax Income -$9.980M -$5.820M -$4.760M
YoY Change 109.66% 9.4% 53.55%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.981M -$5.816M -$4.755M
YoY Change 109.91% 9.24% 38.11%
Net Earnings / Revenue -3219.68% -1103.61% -79250.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$129.5K -$90.02K -$107.2K
COMMON SHARES
Basic Shares Outstanding 75.99M shares 75.99M shares 44.36M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $110.8M $70.40M $26.30M
YoY Change 321.29% 117.28% 1.94%
Cash & Equivalents $48.46M $70.39M $26.27M
Short-Term Investments $62.30M
Other Short-Term Assets $1.700M $1.300M $1.400M
YoY Change 21.43% -31.58% -22.22%
Inventory
Prepaid Expenses $481.0K $683.0K $293.0K
Receivables $16.00K $0.00 $0.00
Other Receivables $300.0K $0.00 $0.00
Total Short-Term Assets $112.8M $71.75M $27.66M
YoY Change 307.68% 108.8% 0.09%
LONG-TERM ASSETS
Property, Plant & Equipment $2.099M $1.597M $1.061M
YoY Change 97.83% 41.33% -19.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $32.00K $456.0K $32.00K
YoY Change 0.0% 1325.0% 0.0%
Total Long-Term Assets $2.487M $2.053M $1.093M
YoY Change 127.54% 76.68% -18.98%
TOTAL ASSETS
Total Short-Term Assets $112.8M $71.75M $27.66M
Total Long-Term Assets $2.487M $2.053M $1.093M
Total Assets $115.3M $73.81M $28.76M
YoY Change 300.83% 107.75% -0.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.814M $1.110M $500.0K
YoY Change 262.8% -17.23% -52.34%
Accrued Expenses $2.435M $2.237M $1.543M
YoY Change 57.81% -26.29% 21.21%
Deferred Revenue $21.87M $14.00K $0.00
YoY Change -100.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.965M $4.912M $0.00
YoY Change -0.28%
Total Short-Term Liabilities $31.09M $8.273M $2.043M
YoY Change 1421.63% -11.06% -39.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $4.925M
YoY Change -100.0% 1.44%
Other Long-Term Liabilities $0.00 $144.0K $39.00K
YoY Change -100.0% 242.86% -85.97%
Total Long-Term Liabilities $0.00 $144.0K $4.964M
YoY Change -100.0% 242.86% -3.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.09M $8.273M $2.043M
Total Long-Term Liabilities $0.00 $144.0K $4.964M
Total Liabilities $34.52M $8.854M $7.804M
YoY Change 342.29% -14.27% -13.4%
SHAREHOLDERS EQUITY
Retained Earnings -$81.30M -$71.32M -$54.99M
YoY Change 47.83% 41.95% 63.6%
Common Stock $9.000K $8.000K $4.000K
YoY Change 125.0% 100.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $80.75M $64.95M $20.95M
YoY Change
Total Liabilities & Shareholders Equity $115.3M $73.81M $28.76M
YoY Change 300.83% 107.75% -0.8%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q4
OPERATING ACTIVITIES
Net Income -$9.981M -$5.816M -$4.755M
YoY Change 109.91% 9.24% 38.11%
Depreciation, Depletion And Amortization $120.0K $100.0K $90.00K
YoY Change 33.33% 11.11% 28.57%
Cash From Operating Activities $15.33M -$5.010M -$5.970M
YoY Change -356.78% 19.57% 11.8%
INVESTING ACTIVITIES
Capital Expenditures -$620.0K -$400.0K -$20.00K
YoY Change 3000.0% 3900.0% -90.0%
Acquisitions
YoY Change
Other Investing Activities -$62.35M
YoY Change
Cash From Investing Activities -$62.97M -$400.0K -$20.00K
YoY Change 314750.0% 3900.0% -90.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.71M 58.64M -180.0K
YoY Change -14383.33% 189.44% -102.15%
NET CHANGE
Cash From Operating Activities 15.33M -5.010M -5.970M
Cash From Investing Activities -62.97M -400.0K -20.00K
Cash From Financing Activities 25.71M 58.64M -180.0K
Net Change In Cash -21.93M 53.23M -6.170M
YoY Change 255.43% 231.44% -318.02%
FREE CASH FLOW
Cash From Operating Activities $15.33M -$5.010M -$5.970M
Capital Expenditures -$620.0K -$400.0K -$20.00K
Free Cash Flow $15.95M -$4.610M -$5.950M
YoY Change -368.07% 10.29% 15.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
516000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1300000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
511000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1439000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
71000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
139000 USD
CY2018Q4 us-gaap Assets
Assets
28756000 USD
CY2019Q3 us-gaap Assets
Assets
73806000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
27663000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
71753000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
14000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
14000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-13000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001698530
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75994790 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
EXICURE, INC.
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
500000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1110000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1543000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2237000 USD
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1786000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
189000 USD
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
255000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1189000 USD
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1454000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75942000 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
136260000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
365000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
419000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
516000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
489000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
339000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14000 USD
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
1034000 USD
CY2019Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4999000 USD
CY2019Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
87000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25764000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32446000 USD
CY2019Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
100000 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
100000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26268000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70392000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6682000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0287
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
44124000 USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
439000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
511000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
6000 USD
CY2018Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
90000 USD
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44358000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75994790 shares
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-237000 USD
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44358000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75994790 shares
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
266000 USD
CY2019Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
91000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
265000 USD
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
10000 USD
CY2019Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
16000 USD
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
899000 USD
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
781000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2574000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
461000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-360000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1919000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5952000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2228000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6421000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
278000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
618000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1602000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
176000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
46000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-3000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-236000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
170000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-135000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
28000 USD
us-gaap Interest Expense
InterestExpense
497000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
203000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
47000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
7804000 USD
us-gaap Interest Expense
InterestExpense
589000 USD
CY2018Q3 us-gaap Interest Paid Net
InterestPaidNet
146000 USD
us-gaap Interest Paid Net
InterestPaidNet
425000 USD
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
152000 USD
us-gaap Interest Paid Net
InterestPaidNet
453000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
210000 USD
us-gaap Lease Cost
LeaseCost
590000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
470000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
59000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
353000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
58000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
8854000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28756000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73806000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2043000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8273000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
4925000 USD
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
4912000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
4912000 USD
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4999000 USD
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4925000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20271000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58599000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-462000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13524000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14013000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-5509000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-6825000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-5324000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17658000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-5286000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5220000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-5816000 USD
us-gaap Net Income Loss
NetIncomeLoss
-16322000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
539000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-707000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
130000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
186000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
5920000 USD
us-gaap Operating Expenses
OperatingExpenses
17063000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
339388 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
617009 shares
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5863000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16951000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5946000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16508000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
84000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
252000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
423000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
279000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
6473000 USD
us-gaap Operating Expenses
OperatingExpenses
17494000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
144000 USD
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
207000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
634000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
424000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.161
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y5M
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
759000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
347000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
59000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
353000 USD
CY2018Q3 us-gaap Operating Leases Rent Expense Contingent Rentals
OperatingLeasesRentExpenseContingentRentals
67000 USD
us-gaap Operating Leases Rent Expense Contingent Rentals
OperatingLeasesRentExpenseContingentRentals
231000 USD
CY2018Q3 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
83000 USD
us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
249000 USD
CY2018Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
150000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
480000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
122000 USD
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
578000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
39000 USD
CY2019Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
0 USD
CY2018Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
32000 USD
CY2019Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
32000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
456000 USD
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
645000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
144000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
381000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
709000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-210000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
333000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
775000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
291000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
36000 USD
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
736000 USD
CY2019Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
638000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0256
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.96
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
52000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
284000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
65000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
462000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1382000 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1345000 USD
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1354000 USD
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
293000 USD
CY2019Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
683000 USD
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
353000 USD
CY2019Q3 us-gaap Prepaid Insurance
PrepaidInsurance
24000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22001000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
63250000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2250000 USD
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3051000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1061000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1597000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4001000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11111000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4245000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11073000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54994000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71316000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
527000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
986000 USD
CY2018Q3 us-gaap Revenues
Revenues
57000 USD
us-gaap Revenues
Revenues
112000 USD
CY2019Q3 us-gaap Revenues
Revenues
527000 USD
us-gaap Revenues
Revenues
986000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1300000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1439000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0272
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0169
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.824
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.867
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.781
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.832
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.806
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.849
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3884020 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.94
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
51000 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4891588 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5157419 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.22
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.24
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
3753000 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
7330000 USD
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3754000 USD
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5082248 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.23
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.45
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.89
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.75
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3718000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y5M
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
42000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
79000 USD
us-gaap Stock Issued1
StockIssued1
436000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11790 shares
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
436000 USD
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20070000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
58866000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
19975000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
16308000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
9902000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
25198000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
20952000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
16155000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
11391000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
64952000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
21009000 USD
CY2018Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3000 USD
CY2019Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
0 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
84000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
259000 USD
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41527922 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40121295 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
64651040 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51200072 shares
CY2018Q4 xcur Accrued Clinical Contract Research And Manufacturing Costs Current
AccruedClinicalContractResearchAndManufacturingCostsCurrent
102000 USD
CY2019Q3 xcur Accrued Clinical Contract Research And Manufacturing Costs Current
AccruedClinicalContractResearchAndManufacturingCostsCurrent
244000 USD
CY2018Q4 xcur Accruedloanfees
Accruedloanfees
231000 USD
CY2019Q3 xcur Accruedloanfees
Accruedloanfees
100000 USD
xcur Amortization Of Operating Lease Assets
AmortizationOfOperatingLeaseAssets
0 USD
xcur Amortization Of Operating Lease Assets
AmortizationOfOperatingLeaseAssets
249000 USD
CY2019Q3 xcur Common Stock Voting Rightsfor Each Share
CommonStockVotingRightsforEachShare
1 vote_per_share
CY2018Q4 xcur Common Stock Warrant Liability
CommonStockWarrantLiability
797000 USD
CY2019Q3 xcur Common Stock Warrant Liability
CommonStockWarrantLiability
437000 USD
xcur Fair Value Assumptions Impact Of10 Percent Change In Expected Volatility Rate
FairValueAssumptionsImpactOf10PercentChangeInExpectedVolatilityRate
44000 USD
xcur Fair Value Assumptions Impact Of10 Percent Change In Fair Value Of Common Stock
FairValueAssumptionsImpactOf10PercentChangeInFairValueOfCommonStock
73000 USD
CY2019Q3 xcur Lease Liability
LeaseLiability
423000 USD
xcur Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
1771000 USD
xcur Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
4384000 USD
xcur Paymentsfor License Agreements
PaymentsforLicenseAgreements
4143000 USD
CY2019Q3 xcur Retained Earnings Accumulated Deficit Inceptionto Date
RetainedEarningsAccumulatedDeficitInceptiontoDate
-90153000 USD
xcur Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.05
xcur Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.05
xcur Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction
StockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
160000 USD
xcur Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction
StockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on certain assumptions which it believes are reasonable in the circumstance and while actual results could differ from those estimates, management does not believe that any change in those assumptions in the near term would have a significant effect on the Company&#8217;s financial position, results of operations or cash flows. Actual results in future periods could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001698530-19-000146-index-headers.html Edgar Link pending
0001698530-19-000146-index.html Edgar Link pending
0001698530-19-000146.txt Edgar Link pending
0001698530-19-000146-xbrl.zip Edgar Link pending
exicure10q93019.htm Edgar Link pending
exicureexhibit311-93019.htm Edgar Link pending
exicureexhibit312-93019.htm Edgar Link pending
exicureexhibit321-93019.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xcur-20190930.xml Edgar Link completed
xcur-20190930.xsd Edgar Link pending
xcur-20190930_cal.xml Edgar Link unprocessable
xcur-20190930_def.xml Edgar Link unprocessable
xcur-20190930_lab.xml Edgar Link unprocessable
xcur-20190930_pre.xml Edgar Link unprocessable